Table 3.
 Participants reporting global improvement in symptoms and showing progression of medial tibial and femoral cartilage defects according to insole group. Values are numbers (percentages) unless stated otherwise
Outcome | Wedge insoles (n=82) | Control insoles (n=85) | Relative risk (95 CI) |
---|---|---|---|
Global improvement in pain* | 57 (70) | 55 (64) | 1.09 (0.88 to 1.35) |
Global improvement in function* | 46 (56) | 53 (62) | 0.91 (0.71 to 1.17) |
Progression of medial tibial cartilage defects | 13 (16) | 18 (21) | 0.75 (0.39 to 1.43) |
Progression of medial femoral cartilage defects | 16 (20) | 18 (21) | 0.92 (0.51 to 1.68) |
*Participants rating themselves as much better or slightly better.